Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab

Eur J Intern Med. 2008 Oct;19(6):e32-3. doi: 10.1016/j.ejim.2007.11.014. Epub 2008 Mar 10.

Authors

J A Montes-Romero¹, J L Callejas-Rubio, D Sánchez-Cano, F J González-Martínez, A Navas-Parejo, N Ortego-Centeno

Affiliation

¹ Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario San Cecilio, Granada, Spain.

PMID: 18848164
DOI: 10.1016/j.ejim.2007.11.014

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Amyloidosis / drug therapy
Amyloidosis / etiology*
Anti-Inflammatory Agents / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Hidradenitis Suppurativa / complications*
Hidradenitis Suppurativa / drug therapy
Humans
Infliximab
Male
Treatment Outcome

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Infliximab